What is Artiva Biotherapeutics, Inc.'s AOCI?

Artiva Biotherapeutics, Inc. (ARTV) reported AOCI of -$18K in Q1 2026.

What is the long-term trend for Artiva Biotherapeutics, Inc.'s AOCI?

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s AOCI has grown at a -42.2% compound annual growth rate (CAGR), from $308K to $103K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Artiva Biotherapeutics, Inc. ARTV AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Gilead SciencesGILD

$78M-15.2%

Kyverna Therapeutics, Inc.KYTX

-$96K-9,500%

Allogene TherapeuticsALLO

-$183K-526%

Immix Biopharma, Inc.IMMX

$105.64K+583%

ImmunityBio, Inc.IBRX

$27.45M+37.6%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s AOCI?: Artiva Biotherapeutics, Inc. (ARTV) reported AOCI of -$18K in Q1 2026.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s AOCI?: Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s AOCI has grown at a -42.2% compound annual growth rate (CAGR), from $308K to $103K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.